Discovery Life Sciences Opens Up 54K SF New Lab & Office in Greater Boston

Discovery Life Sciences has opened a new office and laboratory at 200 Exchange St. in Malden, Massachusetts. This facility spans over 53,000 square feet and represents the company’s seventh location in the United States and its third in the Greater Boston area, alongside its existing sites in Woburn and Quincy.

Supporting Pharma and Biotech Industries

The Malden facility is designed to meet the needs of the region's dynamic pharmaceutical and biotech sectors. It will host Discovery's Gentest products and services, focusing on in vitro preclinical studies for drug metabolism and predictive toxicology. Additionally, the facility includes a clean room and cell processing laboratory, bolstering its AllCells offerings, which provide high-quality cell and gene therapy cryo-preserved GMP products on the East Coast.

Commitment to Therapeutic Solutions

Discovery’s CEO, Greg Herrema, emphasized the significance of the new facility in advancing therapeutic solutions to improve patient outcomes. He highlighted that the expansion in the Greater Boston area addresses growing customer demand and enhances the company's capacity to deliver cutting-edge cell and gene therapy solutions to biopharma customers in the New England region.

Strategic Investment in a Biotech Hub

Marshall Schreeder, president of Discovery's preclinical division, noted the importance of the Greater Boston area as a global hub for biotech and pharmaceutical research. He stated that the new Malden facility would be pivotal in supporting the growth of the Gentest business, providing advanced capabilities for drug metabolism studies and predictive toxicology, crucial for drug discovery and development.

Global Operations and Comprehensive Support

Discovery Life Sciences operates globally, with laboratories and offices across the United States and Europe. This extensive network allows the company to offer comprehensive support to the life sciences industry worldwide, reinforcing its role as a trusted partner in life sciences research and clinical development.